Stargardt Disease
Article Sidebar
Main Article Content
Abstract
Relevance: Stargardt disease is a retinal pathology that must be treated by the necessary professionals, and it is the duty of the optometrist to attempt to provide the patient with visual aids that can improve their quality of life and enable them to carry out daily activities with more precision.
Summary: Any optometrist is nowadays a highly useful tool in an increasingly computerized world. Conditions like Stargardt disease can be treated as a central vision problem, and closer to home, the well-known AMD (Age-related Macular Degeneration) leaves more patients lost each day as they are deprived of central vision. Therefore, it is essential for optometrists to educate themselves and offer the best vision and quality of life to their patients. As the first line of visual care, optometrists have among their many roles the duty to understand the various eye conditions that can affect vision. One of the lesser-known visual pathologies is Stargardt disease (SD). SD is a condition that affects the central retina, causing central vision problems and reducing the patient's quality of life from the onset. Hence, the objective of this article is to conduct a literature review on the topic and contribute to the dissemination of knowledge about this disease.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
References
- Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997 Mar; 15 (3): 236-46.
- Riveiro-Alvarez R, Aguirre-Lamban J, Lopez – Martinez MA, Trujillo – Tiebas MJ, Cantalapiedra D, Vallespin E. et al. Frequency of ABCA4 mutations in 278 Spanish controls: an insight into the prevalence of autosomal recessive Stargardt disease. Br J Ophthalmol. 2009; 93 (10): 1359 - 1364
- Acosta R, Hoffmeister L, Román R, Comas M, Castilla M, Castells X. Systematic review of population-based studies of the prevalence of cataracts. Arch Soc Esp Oftalmol. 2006; 81 (9): 509-16.
- Riveiro-Alvarez R, Vallespin E, Wilke R, Garcia-Sandoval B, Cantalapiedra DAguirre-Lamban J et al. Molecular analysis of ABCA4 and CRB1 genes in a Spanish family segregating both Stargardt disease and autosomal recessive retinitis pigmentosa. Mol Vis. 2008; 14 (2): 262-7.
- Weleber R. G. Stargardt’s Macular Dystrophy. Archives of Ophthalmology. 1994; 112 (6): 752 – 754.
- Enciclopedia Médica A.D.A.M. [Internet]. Atlanta (GA): A.D.A.M., Inc.; ©2005. Autosómico recesivo; [actualizado 16 may 2012; consulta 15 de may 2014].
- Sohrab MA, Allikmets R, Guarnaccia MM, Smith RT. Preimplantation genetic diagnosis for stargardt disease. Am J Ophthalmol 2010; 149 (4): 651-655.
- Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997 Mar; 15 (3): 236-46.
- Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science. 1997. 19; 277(5333): 1805-7.
- Molday RS, Zhang K. Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration. Prog Lipid Res. 2010; 49 (4): 476 – 92.
- Distrofias hereditarias del fondo de ojo. En: Kanski JJ. Oftalmología clínica. Quinta edición. Elsevier; 2004. p. 506 – 507.
- Coco Martin RM, Navarro Alemany, RM. Guía clínica para el diagnóstico diferencial y el manejo de las enfermedades hereditarias de la retina y la coroides. Sociedad Española de Retina y Vítreo 2009.
- Shastry BS. Evaluation of the common variants of the ABCA4 gene in families with Stargardt disease and autosomal recessive retinitis pigmentosa. Int J Mol Med 2008; 21: 715-720.
- Fernández Velazquez FJ. Tratamiento optométrico de la enfermedad de stargardt: Caso clínico. Gaceta óptica 1993; 18-26.
- Pérez M. A, García R, Gomez, L., Soler, M., Rodriguez, A., Bautista, I et al. Tratamiento optométrico de la enfermedad de Stargardt. Gaceta Óptica 1998; 314:10-16.
- Lois N, Holder GE, Fitzke FW, Plant C, Bird AC. Intrafamilial variation of phenotype in Stargardt Macular Dystrophy-Fundus Flavimaculatus. Invest Ophthalmol Vis Sci1999; 40: 2668-2675.
- North V, Gelman R, Tsang SH. Juvenile-onset macular degeneration and allied disorders. Dev Ophthalmol 2014; 53 (4): 44-52.
- Duncker T, Lee W, Tsang SH, Greenberg JP, Zernant J, Allikmets R, et al. Distinct characteristics of inferonasal fundus autofluorescence patterns in stargardt disease and retinitis pigmentosa. Invest Ophthalmol Vis Sci 2013; 54 (10): 6820-6.
-Torcal Villarrubia B, Carrascosa Ibáñez D. Distrofia macular viteliforme o enfermedad de Best. A propósito de un caso. Gaceta de Optometría y óptica oftálmica 2013; 484 (9): 34–36.
- Cubas – Lorenzo V, Gutiérrez JC, López Ramos L. Enfermedad de Stargardt con fondo flavimaculatus y degeneración de la capa de fibras nerviosas de la retina semejando glaucoma. Presentación de un caso y su progresión en diez años. Rev Mex Oftalmol 2008; 82 (3): 179-183.
- Distrofias hereditarias del fondo de ojo. En: Kanski JJ. Oftalmología clínica. Quinta edición. Elsevier; 2004. p. 508 – 509.
- Padilla Pérez CA, Leiva González Y, Herrera Lazo Z. "Enfermedad de Stargardt con fondo flavimaculatus. Presentación de un caso." Mediciego 2010; 16 (1).
- Distrofias hereditarias del fondo de ojo. En: Kanski JJ. Oftalmología clínica. Quinta edición. Elsevier; 2004. p. 518.
- Distrofias hereditarias del fondo de ojo. En: Kanski JJ. Oftalmología clínica. Quinta edición. Elsevier; 2004. p. 514.
- Orozco-Gómez, LP, Ruiz-Morfín, I. Maculopatía en ojo de buey. Rev Mex Oftalmol 2005; 79(1): 51-3.
- Ferreras A, Pinilla I, Abecia E, Pajarín A.B, Honrubia FM. Toxicidad retiniana secundaria a tratamiento con cloroquina. Arch Soc Esp Oftalmol 2007; 82 (2): 103–8.